Log in

Relevant bibliographies by topics / Benign prostatic hyperplasia / Dissertations / Theses

To see the other types of publications on this topic, follow the link: Benign prostatic hyperplasia.

Dissertations / Theses on the topic 'Benign prostatic hyperplasia'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Benign prostatic hyperplasia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Jia, Guang. "MR imaging biomarkers for benign prostatic hyperplasia pharmacotherapy." Columbus, Ohio : Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1164686290.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ambrosini, Gina L. "Dietary risk factors for prostate cancer and benign prostatic hyperplasia." University of Western Australia. School of Population Health, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0135.

Full text

Abstract:

[Truncated abstract] This thesis examines the potential role of dietary intake in the development of two common conditions affecting the prostate gland; prostate cancer and benign prostatic hyperplasia (BPH). Diet is of interest as a potential risk factor for prostate cancer because of geographical variations in prostate cancer incidence and increased prostate cancer risks associated with migration from Asian to western countries. Some geographical variation has been suggested for BPH, but this is less certain. However, both prostate cancer and BPH have potential links with diet through their

APA, Harvard, Vancouver, ISO, and other styles

3

Woo, Henry Hyunshik. "Evolution of minimally invasive surgical treatments for benign prostatic obstruction." Thesis, The University of Sydney, 2016. http://hdl.handle.net/2123/15772.

Full text

Abstract:

Transurethral resection of the prostate (TURP) has been the established surgical gold standard for the treatment of prostatic obstruction due to benign prostatic hyperplasia(BPH). Prior to TURP, the mainstay of surgical treatment was open suprapubic prostatectomy (SPP), which carried a high risk of morbidity and mortality. TURP did not go through rigorous assessment of outcomes or comparison with SPP in order to become labeled as the gold standard. TURP is still a procedure with potential significant morbidity, particular with regard to hemorrhage and surgical misadventure. In the mid to

APA, Harvard, Vancouver, ISO, and other styles

4

Gilmore, Paul Edward. "Isolation and characterization of stem cell phenotype in benign prostatic hyperplasia and prostate cancer." Thesis, University of Manchester, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.492891.

Full text

Abstract:

The prostate epithelial stem cell has been proposed as the primary origin of neoplastic change in prostate cancer. However, due to a lack of specific markers, such cells have been profoundly difficult to isolate. We propose that the Hoechst 33342 dye efflux assay 'Side Population' originally developed to isolate a stem cell enriched haemopoietic stem cell population from bone marrow provides a method for identifying the cancer stem cell origin in prostatic adenocarcinoma.

APA, Harvard, Vancouver, ISO, and other styles

5

Chan, Hin-cheong. "The psychometric evaluation of the Chinese version of the international prostate symptom score (IPSS)." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31972871.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Noble, Amanda Jane. "The alphaâ†1-andrenoceptor subtype mediating contraction of the lower urinary tract." Thesis, University of Sheffield, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.284384.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Xu, Kexin. "Identification and evaluation of specific marker proteins associated with human benign peostate [sic] hyperplasia /." Hong Kong : University of Hong Kong, 2002. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25435863.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Fernandes, Ancilla W. "Evaluating diagnostic and treatment modalities in the management of benign prostatic hyperplasia in the Veterans Administration population." Morgantown, W. Va. : [West Virginia University Libraries], 2000. http://etd.wvu.edu/templates/showETD.cfm?recnum=1543.

Full text

Abstract:

Thesis (M.S.)--West Virginia University, 2000.<br>Title from document title page. Document formatted into pages; contains ix, 154 p. : ill. Includes abstract. Includes bibliographical references (p. 137-143).

APA, Harvard, Vancouver, ISO, and other styles

9

Tayeb, Mohammed Taher. "Genetic risk factors influencing the development of prostate cancer in patients with benign prostatic hyperplasia." Thesis, University of Aberdeen, 2002. http://digitool.abdn.ac.uk/R?func=search-advanced-go&find_code1=WSN&request1=AAIU154536.

Full text

Abstract:

The primary aim of this study is to assess the predictive value of six molecular markers in determining PRCa risk in patients with BPH. These molecular markers are: (A)- Two polymorphic repeats, (CAG)<sub>n</sub> and (GGN)<sub>n</sub>, in the androgen receptor (<i>AR</i>) gene; (B)- A single nucleotide polymorphism (SNP) in the (-290 A to G) 5' regulatory region of the <i>CYP3A4 </i>gene; (C)- Two SNPs (<i>Taq</i>I and <i>Fok</i>I) in vitamin D receptor (<i>VDR</i>) gene; (D)- A SNP (Val655Ile) in the transmembrane domain coding region of <i>HER2</i> gene. The study evaluated 28 patients who p

APA, Harvard, Vancouver, ISO, and other styles

10

Hallin, Anders. "Transurethral microwave thermotherapy of benign prostatic hyperplasia : a clinical and methodological evaluation /." Stockholm, 1997. http://diss.kib.ki.se/1997/91-628-2727-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Herrera, Maria Lourdes C. "The expression of various growth factors in the normal human prostate, benign prostatic hyperplasia, and prostate carcinoma." Thesis, Hong Kong : University of Hong Kong, 1996. http://sunzi.lib.hku.hk/hkuto/record.jsp?B1754628X.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Brehmer, Marianne. "Transurethral microwave thermotherapy of benign prostatic hyperplasia : mechanisms of action and clinical outcome /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3857-1/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Xu, Kexin, and 許克新. "Identification and evaluation of specific marker proteins associated with human benign peostate [sic] hyperplasia." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2002. http://hub.hku.hk/bib/B31226954.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Paul, Alan Burnett. "β-NGF and its low-affinity receptor (p75LNGFR) in benign prostatic hyperplasia and adenocarcinoma of the prostate". Thesis, University of Edinburgh, 1999. http://hdl.handle.net/1842/29936.

Full text

Abstract:

β-NGF was measured in human benign prostatic hyperplastic (BPH), adenocarcinomatous and normal tissues using an enzyme-linked immunosorbent assay. Concentrations were 1992pg/g wet weight in BPH tissue (SD = 684pg/g), 3100pg/g in adenocarcinomatous tissue (SD = 1503pg/g), and 2690pg/g in normal tissue. mRNA transcripts for β-NGF were demonstrated in prostate tissues by reverse transcription-polymerase chain reaction showing that the β-NGF measured in prostate tissue was endogenously produced. Western blotting allowed the demonstration that immunoreactive β-NGF in the prostate represented dimeri

APA, Harvard, Vancouver, ISO, and other styles

15

Maestri, Valentina <1984&gt. "Design and synthesis of multipotent drugs: application to Alzheimer's disease and benign prostatic hyperplasia." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2013. http://amsdottorato.unibo.it/5280/1/Maestri_Valentina_tesi.pdf.

Full text

Abstract:

The aim of this thesis was to synthesize multipotent drugs for the treatment of Alzheimer’s disease (AD) and for benign prostatic hyperplasia (BPH), two diseases that affect the elderly. AD is a neurodegenerative disorder that is characterized, among other factors, by loss of cholinergic neurons. Selective activation of M1 receptors through an allosteric site could restore the cholinergic hypofunction, improving the cognition in AD patients. We describe here the discovery and SAR of a novel series of quinone derivatives. Among them, 1 was the most interesting, being a high M1 selective positiv

APA, Harvard, Vancouver, ISO, and other styles

16

Maestri, Valentina <1984&gt. "Design and synthesis of multipotent drugs: application to Alzheimer's disease and benign prostatic hyperplasia." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2013. http://amsdottorato.unibo.it/5280/.

Full text

Abstract:

The aim of this thesis was to synthesize multipotent drugs for the treatment of Alzheimer’s disease (AD) and for benign prostatic hyperplasia (BPH), two diseases that affect the elderly. AD is a neurodegenerative disorder that is characterized, among other factors, by loss of cholinergic neurons. Selective activation of M1 receptors through an allosteric site could restore the cholinergic hypofunction, improving the cognition in AD patients. We describe here the discovery and SAR of a novel series of quinone derivatives. Among them, 1 was the most interesting, being a high M1 selective positiv

APA, Harvard, Vancouver, ISO, and other styles

17

Almeida, Neto Adauto 1977. "Abordagem quantitativa da expressão do gene WFDC1 e sua isoforma delta 3 = Quantitative approach of the expression of WFDC1 gene and its isoform delta 3." [s.n.], 2014. http://repositorio.unicamp.br/jspui/handle/REPOSIP/317579.

Full text

Abstract:

Orientadores: Hernandes Faustino de Carvalho, Paulo Roberto Eleutério de Souza<br>Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia<br>Made available in DSpace on 2018-08-25T14:18:25Z (GMT). No. of bitstreams: 1 AlmeidaNeto_Adauto_D.pdf: 4167026 bytes, checksum: ca3afd135b583810d6996e33016f9e69 (MD5) Previous issue date: 2014<br>Resumo: A próstata é alvo de afecções severas que comprometem a função urinária, a qualidade de vida e que consistem em risco de vida aos indivíduos do sexo masculino, particularmente com o avançar da idade. Interações dinâmicas entre o epit

APA, Harvard, Vancouver, ISO, and other styles

18

Hakenberg, Oliver W., Christian Helke, Andreas Manseck, and Manfred P. Wirth. "Is There a Relationship between the Amount of Tissue Removed at Transurethral Resection of the Prostate and Clinical Improvement in Benign Prostatic Hyperplasia." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-134714.

Full text

Abstract:

Objective: To assess in a prospective trial the influence of the amount of tissue resected at transurethral resection of the prostate (TURP) for benign prostatic enlargement on the symptom improvement as assessed by symptom scores. Methods: Between December 1996 and August 1998 a total of 138 men (mean age 68.2, range 53–89) with symptomatic benign prostatic enlargement who underwent TURP participated in this prospective study. Patients were assessed preoperatively with the International Prostate Symptom Score (IPSS), the American Urological Association Bother Score (AUA–BS) and the Benign Pro

APA, Harvard, Vancouver, ISO, and other styles

19

Dilmen, Cem Perk Hakkı. "Prostat kanserli hastalarda leptin düzeylerinin araştırılması /." Isparta: SDÜ Tıp Fakültesi, 2004. http://tez.sdu.edu.tr/Tezler/TT00200.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Chan, Hin-cheong, and 陳顯昌. "The psychometric evaluation of the Chinese version of the international prostate symptom score (IPSS)." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B31972871.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Fröhner, Michael, Oliver W. Hakenberg, Rainer Koch, Uta Schmidt, Axel Meye, and Manfred P. Wirth. "Comparison of the Clinical Value of Complexed PSA and Total PSA in the Discrimination between Benign Prostatic Hyperplasia and Prostate Cancer." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-133807.

Full text

Abstract:

Background: To compare the clinical value of the measurement of complex and total PSA in the discrimination between benign prostatic hyperplasia (BPH) and prostate cancer. Methods: In serum samples collected from 166 men with histopathologically proven clinically localized prostate cancer and of 97 men with BPH, total prostate-specific antigen (PSA), complexed PSA and the free to total PSA ratio were determined. The statistical analysis was done by the comparison of the receiver operator characteristic (ROC) curves. Results: The areas under the ROC curves were 0.776 for total PSA, 0.799 for co

APA, Harvard, Vancouver, ISO, and other styles

22

Hatfield, Meghan. "PROSTASIN IS EXPRESSED IN BENIGN PROSTATIC HYPERPLASIA AND REGULATES CELL PROLIFERATION AND INVASION VIA INOS, ICAM-1, AND CYCLI." Master's thesis, University of Central Florida, 2008. http://digital.library.ucf.edu/cdm/ref/collection/ETD/id/4260.

Full text

Abstract:

ABSTRACT Prostasin is expressed in normal prostate epithelial cells but down-regulated in prostate cancers, while prostasin re-expression in invasive prostate cancer cells reduced invasion. We examined prostasin expression and function in benign prostatic hyperplasia (BPH). We evaluated prostasin expression in 12 BPH specimens by immunohistochemistry, and evaluated the impact of prostasin silencing by siRNA on the expression of the inducible nitric oxide synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1), and cyclin D1, as well as on cell proliferation and invasion, using the BPH-1 hu

APA, Harvard, Vancouver, ISO, and other styles

23

VASCONCELOS, Juliana Lúcia de Albuquerque. "Avaliação do valor diagnóstico e prognóstico do carboidrato L-fucose e das fucosiltransferases 3 e 6 em tumores prostáticos humano." Universidade Federal de Pernambuco, 2012. https://repositorio.ufpe.br/handle/123456789/18485.

Full text

Abstract:

Submitted by Caroline Falcao (caroline.rfalcao@ufpe.br) on 2017-04-04T19:33:58Z No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) 2012-Dissertação-JulianaVasconcelos.pdf: 1176748 bytes, checksum: bb96bcabc13f8fef386568e90cfdc033 (MD5)<br>Made available in DSpace on 2017-04-04T19:33:58Z (GMT). No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) 2012-Dissertação-JulianaVasconcelos.pdf: 1176748 bytes, checksum: bb96bcabc13f8fef386568e90cfdc033 (MD5) Previous issue date: 2012<br>Câncer é um conjunto de altera

APA, Harvard, Vancouver, ISO, and other styles

24

Hakenberg, Oliver W., Christian Helke, Andreas Manseck, and Manfred P. Wirth. "Is There a Relationship between the Amount of Tissue Removed at Transurethral Resection of the Prostate and Clinical Improvement in Benign Prostatic Hyperplasia." Karger, 2001. https://tud.qucosa.de/id/qucosa%3A26541.

Full text

Abstract:

Objective: To assess in a prospective trial the influence of the amount of tissue resected at transurethral resection of the prostate (TURP) for benign prostatic enlargement on the symptom improvement as assessed by symptom scores. Methods: Between December 1996 and August 1998 a total of 138 men (mean age 68.2, range 53–89) with symptomatic benign prostatic enlargement who underwent TURP participated in this prospective study. Patients were assessed preoperatively with the International Prostate Symptom Score (IPSS), the American Urological Association Bother Score (AUA–BS) and the Benign Pr

APA, Harvard, Vancouver, ISO, and other styles

25

Sahlén, Göran. "Formation, storage and secretion of prostasomes in benign and malignant cells and their immunogenicity in prostate cancer patients /." Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7511.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Fröhner, Michael, Oliver W. Hakenberg, Rainer Koch, Uta Schmidt, Axel Meye, and Manfred P. Wirth. "Comparison of the Clinical Value of Complexed PSA and Total PSA in the Discrimination between Benign Prostatic Hyperplasia and Prostate Cancer." Karger, 2006. https://tud.qucosa.de/id/qucosa%3A27537.

Full text

Abstract:

Background: To compare the clinical value of the measurement of complex and total PSA in the discrimination between benign prostatic hyperplasia (BPH) and prostate cancer. Methods: In serum samples collected from 166 men with histopathologically proven clinically localized prostate cancer and of 97 men with BPH, total prostate-specific antigen (PSA), complexed PSA and the free to total PSA ratio were determined. The statistical analysis was done by the comparison of the receiver operator characteristic (ROC) curves. Results: The areas under the ROC curves were 0.776 for total PSA, 0.799 for

APA, Harvard, Vancouver, ISO, and other styles

27

MIYAKE, KOJI, HATSUKI HIBI, and MASANORI YAMAMOTO. "A COMPARISON OF TRANSURETHRAL RESECTION OF THE PROSTATE AND MEDICAL TREATMENT FOR THE PATIENT WITH MODERATE SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA." Nagoya University School of Medicine, 1996. http://hdl.handle.net/2237/16096.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Kelly-Blake, Karen Denise. "Sexual (dys)function and benign prostate disease implications for health care decision-making /." Diss., Connect to online resource - MSU authorized users, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Monjardez, Geraldine. "The feasibility of Fourier transform infrared imaging spectroscopy in discriminating benign prostatic hyperplasia from prostate cancer in blood serum samples." Thesis, University of Manchester, 2013. https://www.research.manchester.ac.uk/portal/en/theses/the-feasibility-of-fourier-transform-infrared-imaging-spectroscopy-in-discriminating-benign-prostatic-hyperplasia-from-prostate-cancer-in-blood-serum-samples(b0fbd4e3-4a23-4696-a480-c83be32a671c).html.

Full text

Abstract:

The feasibility of Fourier transform infrared (FTIR)-imaging spectroscopy as a tool to discriminate samples from patients suffering from benign prostatic hyperplasia (BPH) and prostate cancer (CaP) samples in blood serum was investigated. Prostate cancer is known to be an age related disease, with the risk of developing the disease dramatically increasing in men past forty years old. Currently the PSA blood test is notoriously unreliable and is non specific for CaP thus leading to overtreatment of the disease. It is important therefore to develop diagnostic method that is non-invasive, reliabl

APA, Harvard, Vancouver, ISO, and other styles

30

Upreti, Rita. "Metabolic effects of 5α-reductase inhibition in humans". Thesis, University of Edinburgh, 2013. http://hdl.handle.net/1842/11745.

Full text

Abstract:

5α-reductases (5αRs) catalyse reduction of 4-pregnene steroids, most notably the androgen testosterone to its more potent metabolite dihydrotestosterone (DHT). Well-characterised isozymes of 5αR are designated 5αR1 and 5αR2. Inhibitors of 5αR, finasteride (a 5αR2 inhibitor) and dutasteride (a dual 5αR1 and 5αR2 inhibitor), are utilised in conditions where a reduction in androgen action is desired, including benign prostatic hyperplasia. Although 5αR2 is predominantly expressed in reproductive tissues, both isozymes, but particularly 5αR1, are expressed in metabolic tissues including liver and

APA, Harvard, Vancouver, ISO, and other styles

31

Kim, Julie M. "Androgen-induced norepinephrine release in male accessory sex organ smooth muscle growth and differentiation." Morgantown, WV : [West Virginia University Libraries], 1999. http://etd.wvu.edu/templates/showETD.cfm?recnum=417.

Full text

Abstract:

Thesis (Ph. D.)--West Virginia University, 1999.<br>Title from document title page. Document formatted into pages; contains vi, 125 p. : ill. Vita. Includes abstract. Includes bibliographical references (p. 107-122).

APA, Harvard, Vancouver, ISO, and other styles

32

Robert, Grégoire. "Rôle de l'inflammation prostatique chronique dans le développement de l'hyperplasie bénigne de la prostate." Thesis, Paris Est, 2011. http://www.theses.fr/2011PEST0099.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Gunnarsson, Jenny, and Madeleine Lundin. "Benign Prostatahyperplasi. Upplevelser och livskvalitet hos män med benign prostatahyperplasi." Thesis, Malmö högskola, Fakulteten för hälsa och samhälle (HS), 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:mau:diva-24279.

Full text

Abstract:

Benign prostatahyperplasi (BPH) är ett tillstånd som drabbar nästintill samtliga män över 80 år och vilket medför urologiska besvär som kan ha inverkan på livs¬kvaliteten och det dagliga livet. Syftet med denna litteraturstudie var att redogöra för hur män med benign prostatahyperplasi upplever sitt dagliga liv samt hur deras livskvalitet påverkas. En litteraturstudie gjordes utifrån ett systematiskt tillväga¬gångssätt. Litteratursökningen utfördes i databaserna Cinahl, PsycInfo, PubMed samt The Cochrane Library. Både kvantitativa och kvalitativa studier inkluderades vilka kvalitetsgranskades

APA, Harvard, Vancouver, ISO, and other styles

34

Ju, Mingxuan. "Machine Learning for Responsiveness of Medication in Bladder and Prostate Syndromes." Case Western Reserve University School of Graduate Studies / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=case1586449819233263.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Ståhl, Joanna, and Moa Ericzon. "Att leva med icke-malign prostataförändring : en litteraturöversikt." Thesis, Sophiahemmet Högskola, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:shh:diva-3529.

Full text

Abstract:

Bakgrund Icke-maligna prostataförändringar är ett utbrett samhällsproblem och en vanlig anledning till att människor söker sjukvård. Prostatit och benign prostatahyperplasi är två icke-maligna förändringar som kan te sig på olika sätt och kan orsaka lidande hos de drabbade, ofta genom ”lower urinary tract symptoms” och smärta som är vanliga symtom. Att lindra lidande är vårdens uppgift och en sjuksköterskas ansvar. Syfte Syftet med denna litteraturöversikt var att belysa hur det är att leva med en icke-malign prostataförändring. Metod Metoden som användes var icke-systematisk littera

APA, Harvard, Vancouver, ISO, and other styles

36

Zambra, Francis Maria Báo. "Influência dos genes CCR2 e CCR5 em hiperplasia e câncer de próstata." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2012. http://hdl.handle.net/10183/69706.

Full text

Abstract:

A hiperplasia prostática benigna (HPB) e o câncer de próstata (CaP) são duas condições crônicas muito comuns em homens com idade avançada e têm sido relacionadas a processos inflamatórios. As quimiocinas são reconhecidas como mediadores críticos da resposta inflamatória por regular a migração das células imunológicas através da ativação de receptores de quimiocinas na superfície destas células. As quimiocinas estão relacionadas à patogênese tumoral, embora não seja claro de que modo afetam a progressão tumoral humana. O objetivo desse estudo foi investigar a associação de dois polimorfismos de

APA, Harvard, Vancouver, ISO, and other styles

37

Mostachio, Giuliano Queiroz [UNESP]. "Estudo comparativo entre a administração de toxina botulínica “A” e a orquiectomia no tratamento da hiperplasia prostática benigna do cão." Universidade Estadual Paulista (UNESP), 2008. http://hdl.handle.net/11449/89061.

Full text

Abstract:

Made available in DSpace on 2014-06-11T19:23:43Z (GMT). No. of bitstreams: 0 Previous issue date: 2008-02-22Bitstream added on 2014-06-13T18:48:32Z : No. of bitstreams: 1 mostachio_gq_me_jabo.pdf: 1253600 bytes, checksum: c1f946210aa85f9b2c8aa26f7af6e985 (MD5)<br>Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)<br>A hiperplasia prostática benigna (HPB) tem início no animal com um a dois anos de idade, sendo que 80% dos cães com cinco anos apresentam evidências histológicas de sua presença. A fisiopatologia da doença não está totalmente compreendida, no entanto, a diidrotestoster

APA, Harvard, Vancouver, ISO, and other styles

38

Manaia, Jorge Henrique Martins. "Estudo qualitativo e quantitativo dos componentes fibrosos da matriz extracelular e músculo liso da uretra prostática de pacientes com hiperplasia prostática benigna, da zona de transição, de pacientes com hiperplasia prostática benigna." Niterói, 2016. https://app.uff.br/riuff/handle/1/4584.

Full text

Abstract:

Submitted by Ana Lúcia Torres (bfmhuap@gmail.com) on 2017-09-20T15:54:57Z No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) JORGE HENRIQUETESE COM CORREÇÕES DA BANCA JAN 2017.pdf: 4201838 bytes, checksum: f47ae0fb55a2d648c74ac2facf85217d (MD5)<br>Approved for entry into archive by Ana Lúcia Torres (bfmhuap@gmail.com) on 2017-09-20T15:55:06Z (GMT) No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) JORGE HENRIQUETESE COM CORREÇÕES DA BANCA JAN 2017.pdf: 4201838 bytes, checksum: f47ae0fb55a2d648c74ac2facf85217

APA, Harvard, Vancouver, ISO, and other styles

39

Mostachio, Giuliano Queiroz. "Estudo comparativo entre a administração de toxina botulínica "A" e a orquiectomia no tratamento da hiperplasia prostática benigna do cão /." Jaboticabal : [s.n.], 2008. http://hdl.handle.net/11449/89061.

Full text

Abstract:

Orientador: Wilter Ricardo Russiano Vicente<br>Banca: Maria Denise Lopes<br>Banca: Maria Isabel de Mello Martins<br>Resumo: A hiperplasia prostática benigna (HPB) tem início no animal com um a dois anos de idade, sendo que 80% dos cães com cinco anos apresentam evidências histológicas de sua presença. A fisiopatologia da doença não está totalmente compreendida, no entanto, a diidrotestosterona é o principal hormônio envolvido. Recentemente, o efeito da toxina botulínica A (TB-A) foi investigado na próstata, mostrando que esta induz atrofia do parênquima e redução do volume. Como o cão é o únic

APA, Harvard, Vancouver, ISO, and other styles

40

Opoku-Acheampong, Alexander Boadu. "Effect of 5[alpha]-reductase inhibitors on LNCaP cells, Syrian hamster flank organs, and TRAMP mice prostate cancer." Diss., Kansas State University, 2015. http://hdl.handle.net/2097/20352.

Full text

Abstract:

Doctor of Philosophy<br>Department of Human Nutrition<br>Brian L. Lindshield<br>The growth-inhibitory effect of saw palmetto supplements (SPS) with high long-chain fatty acids (FA)-low phytosterols (HLLP), high long-chain FA-high phytosterols (HLHP), and high medium-chain FA-low phytosterols (HMLP) was determined using androgen-sensitive LNCaP prostate cancer (PCa) cells and Syrian hamster flank organs. In vitro, all three SPS at high concentrations significantly decreased dihydrotestosterone-stimulated LNCaP cell number. HMLP and HLLP at high concentrations significantly decreased, but HLHP w

APA, Harvard, Vancouver, ISO, and other styles

41

Trumbeckas, Darius. "Klinikinių ir urodinaminių požymių svarba prognozuojant gerybinės prostatos hiperplazijos chirurginio gydymo rezultatus." Doctoral thesis, Lithuanian Academic Libraries Network (LABT), 2006. http://vddb.library.lt/obj/LT-eLABa-0001:E.02~2006~D_20060126_155100-72148.

Full text

Abstract:

INTRODUCTION Benign prostatic hyperplasia (BPH) is the most common pathological condition of aged men which significantly impairs the quality of life status. Though pharmacotherapy with adrenoblockers and 5-alpha reductase inhibitors markedly decreased the rate of surgical interventions, BPH surgery still constitutes the main workload (around ¼ of total) of urologists in the department. The results of the observational study performed by Barry et al. show that the probability of surgical treatment of BPH during the period of 4 years for subjects with mild symptoms equals to 10%, and in case of

APA, Harvard, Vancouver, ISO, and other styles

42

Pinedo, Pichilingue Aranza, Martín-San Martín Gustavo San, and Nilton Yhuri Carreazo. "Discriminación entre hiperplasia prostática benigna y cáncer de próstata mediante el uso de PSA index en consulta externa de urología." Elsevier B.V, 2016. http://hdl.handle.net/10757/607465.

Full text

Abstract:

El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.<br>Objetivo El antígeno prostático específico es utilizado en el diagnóstico de patologías prostáticas. No existe un estudio en Perú que proponga un punto de corte de PSA index para discriminar entre cáncer de próstata e hiperplasia prostática benigna para la indicación de biopsia prostática. Actualmente, se emplean diferentes puntos de corte basados en estudios internacionales. Material y métodos Se realizó un estudio de validación diagnóstica de

APA, Harvard, Vancouver, ISO, and other styles

43

Santos, Jacqueline Schaurich dos. "Padrão alimentar, perfil antropométrico e lipídico em uma amostra de indivíduos com e sem câncer de próstata ou hiperplasia prostática benigna." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2007. http://hdl.handle.net/10183/10738.

Full text

Abstract:

Patologias prostáticas como a Hiperplasia Prostática Benigna (HPB) e o Câncer de próstata (CaP) apresentam alta incidência, morbidade e mortalidade em indivíduos a partir de 40-50 anos. Fatores ambientais e nutricionais são possíveis fatores envolvidos no desenvolvimento destas doenças. Este trabalho tem por objetivo avaliar o padrão alimentar, perfil antropométrico e perfil lipídico em homens com e sem HPB e CaP e verificar se existe associação entre as variáveis consideradas e a presença de HPB ou CaP na amostra estudada. Foram entrevistados pacientes provenientes do ambulatório de Urologia

APA, Harvard, Vancouver, ISO, and other styles

44

Araújo, Liana Maria Tôrres de. "Anestesia para ressecção transuretral de próstata: comparação entre dois períodos no HC-FMRP-USP." Universidade de São Paulo, 2004. http://www.teses.usp.br/teses/disponiveis/17/17142/tde-06042009-122239/.

Full text

Abstract:

A Hiperplasia Prostática Benigna (HPB) é a doença benigna mais freqüente na terceira idade. A Ressecção Transuretral (RTU) de próstata constitui-se na técnica operatória mais empregada atualmente para o tratamento da HPB. A anestesia para este procedimento possui características próprias, tornando-se um desafio para o anestesiologista o manejo de suas particularidades. Com o objetivo de avaliar a conduta anestésica, comparando técnicas empregadas, drogas e doses, eventuais complicações e respectivos tratamentos, revisou-se 300 prontuários de pacientes submetidos a RTU de próstata no Hospital d

APA, Harvard, Vancouver, ISO, and other styles

45

Miranda, Mariza Abreu. "Solanum cernuum Vell: estudo fitoquímico, avaliação das atividades gastroprotetora, antimicrobiana, citotóxica e obtenção do extrato seco por spray dryer." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/60/60138/tde-25092015-151741/.

Full text

Abstract:

Solanum cernuum Vell. (Solanaceae), popularmente conhecida como \"panacéia\", é uma planta nativa do sul e sudeste do Brasil. Seu nome \"panacéia\" provavelmente é devido à grande amplitude de aplicações que possui na medicina popular: tratamento de úlceras, lesões hepáticas, infecções de pele, como antitumoral, diurético, depurativo, anti-hemorrágico, bem como para o tratamento da gonorreia e da hiperplasia benigna da prostática (HBP). Considerando os usos de S. cernuum na medicina popular brasileira e a escassez de estudos que os corroborrem, propomos neste trabalho, a partir da obtenção de

APA, Harvard, Vancouver, ISO, and other styles

46

Suter, Andy. "New perspectives on saw palmetto (Serenoa repens) : a medico historical / analytical comparison of preparations derived from it and a clinical pilot trial in patients with benign prostatic hyperplasia and sexual dysfunctions." Thesis, University College London (University of London), 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.569065.

Full text

Abstract:

Saw palmetto berries (Sereona repens) are used today for symptoms of benign prostatic hyperplasia (BPH) which is an age dependent disease leading to lower urinary tract symptoms (LUTS) and impacts negatively sexual functions (SDys). I carried out the first clinical pilot trial to assess if a saw palmetto treatment in patients with BPH symptoms and concomitant SDys is efficacious and safe on both groups of symptons. After 8 weeks of treatment with 320mg saw palmetto extract daily, the BPH symptoms assessed with the International Prostate Symptome Score IPSS were reduced from 14.4 ± 4.7 to 6.9 ±

APA, Harvard, Vancouver, ISO, and other styles

47

Neves, Adriana Freitas. "Variações transcricionais dos genes AR, SRD5A2, KLK2, PCA3, KLK3 e PSMA e implicações no diagnóstico molecular do câncer de próstata." Universidade Federal de Uberlândia, 2007. https://repositorio.ufu.br/handle/123456789/15771.

Full text

Abstract:

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior<br>CHAPTER I - Prostate cancer is a common disease in the world and in some countries it is one of the main causes of male population mortality. Some molecular markers have been associated with prostate carcinogenesis. To observe changes in transcript levels of the AR, SRD5A2, KLK2, PSMA and PCA3 genes, the mRNA was analyzed in tissues with prostatic adenocarcinoma (PCa, N= 48) and benign prostatic hyperplasia (BPH, N= 25), performed through a differential multiplex RT-PCR assay. Significant differences were observed in the relative e

APA, Harvard, Vancouver, ISO, and other styles

48

Marklund-Bau, Helén. "Sleep and quality of life in men with lower urinary tract symptoms : and their partners." Doctoral thesis, Linköpings universitet, Hälsouniversitetet, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-15946.

Full text

Abstract:

Aims: The overall aim was to determine how lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) affect sleep, health related quality of life and disease specific quality of life, and how the men’s urinary symptoms affect their partners. Subjects and methods: In papers I–II, a descriptive design with a pre-test and post-test was used and in papers III-IV the design was descriptive and comparative. The method was self-administered questionnaires. In papers I- II: The questionnaires were translated in the ethnographic mode. In paper I the reliability of the questio

APA, Harvard, Vancouver, ISO, and other styles

49

Tacino, Rafael Bozzo. "Efeitos do uso da finasterida sobre o volume prostático e dosagem sérica do PSA em pacientes jovens." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/17/17137/tde-02022016-093721/.

Full text

Abstract:

A indicação de biópsia para o diagnóstico precoce do câncer prostático baseia-se na dosagem sérica do PSA e nos achados do toque retal. O PSA é uma kalecreina estando seus genes reguladores ligados aos andrógenos. Drogas que afetam o metabolismo dos andrógenos podem afetar a produção de PSA. A finasterida é uma droga sintética que inibe a conversão de testosterona em DHT pela enzima 5 AR. O uso da finasterida na dose de 5mg/dia para o tratamento da HPB causa redução do volume prostático de 20 a 30% e diminuição dos valores dos PSA em aproximadamente 50% do seu valor inicial após 6 meses. O uso

APA, Harvard, Vancouver, ISO, and other styles

50

Manseck, Andreas, Christian Pilarsky, Stefan E. Froschermaier, Mario Menschikowski, and Manfred P. Wirth. "Diagnostic Significance of Prostate-Specific Antigen Velocity at Intermediate PSA Serum Levels in Relation to the Standard Deviation of Different Test Systems." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-133947.

Full text

Abstract:

Serial prostate-specific antigen (PSA) measurements (PSA velocity) as an additional instrument to detect prostatic cancer was introduced in 1992. It has previously been reported that PSA increase per year differed in the last 5 years prior to diagnosis in patients with benign prostatic hyperplasia (0.18 ng/ml/year), locally confined (0.75 ng/ml/year) and metastasized (4.4 ng/ml/year) cancer of the prostate (CaP) in contrast to healthy men (0.04 ng/ml/year). The ability of PSA velocity to detect organ-confined CaP in patients with intermediate PSA serum values depends therefore on a reliable an

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!